Biotech

All Articles

Metsera teams up with Amneal to lock down GLP-1 supply

.Along with very early phase 1 records now out in the wild, metabolic ailment outfit Metsera is actu...

Rivus posts information to support muscle-sparing weight problems drug cases

.Rivus Pharmaceuticals has actually unveiled the data behind its own phase 2 obesity succeed in hear...

BMS pays for $110M to form T-cell treatment contract, helping Excellent purchase opportunity to advance prioritized pipe

.Bristol Myers Squibb is paying out Top Medication $110 thousand beforehand to cultivate reagents fo...

Generate increases an additional $1B-plus Big Pharma relationship

.Novartis has actually printer inked an offer possibly worth greater than $1 billion along with Flag...

Metsera GLP-1 information slice shows 7.5% effective weight loss at 36 days

.Lately debuted Metsera is actually unfolding some stage 1 data for its own GLP-1 receptor agonist, ...

Flagship really hopes biotechs group to Mirai to improve hereditary medications

.In the middle of the genetic medicines branches race, Front runner Pioneering is introducing a new ...

BioAge eyes $180M from IPO, private placement for excessive weight trials

.BioAge Labs is actually considering around $180 million in first earnings coming from an IPO and a ...

Merck's LAG-3 combo falls short intestines cancer period 3 research

.An effort through Merck &amp Co. to uncover the microsatellite stable (MSS) metastatic colorectal c...

Spanish VC closes $200M life sciences fund

.Spain-based Asabys Allies has closed a fund of 180 million europeans ($ 200 thousand), loan that wi...

BioAge brings in $198M from IPO as excessive weight biotech signs up with Nasdaq

.BioAge Labs is bringing in almost $200 thousand using its own Nasdaq IPO today, with the earnings e...